From July 27 to 30, 2020, the Company accepted and passed the patrol inspection and inspection by the Center for Food and Drug Inspection of NMPA regarding the Haemophilus Influenzae Type b Conjugate Vaccine.

The inspection is detailed in the following table. Besides, no penalties were made against the Company’s products due to quality since their launch.

Inspection Statistics